Chemotherapy Combined with ICIs in First-line Alectinib Failed Patients with ALK-rearranged NSCLC

Clinical trial NCT04997382 · COMPLETED

Trial details

NCT number: NCT04997382
Sponsor: Hunan Province Tumor Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer

Start date: 2021-08-17
Primary completion: 2024-01-31
Enrollment: 112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.